Dr Agarwal’s vs KIMS: Which healthcare firm is poised for greater growth?
Subscribe to enjoy similar stories. The healthcare industry in India was valued at $372 billion in 2023 and is projected to reach $638 billion by the end of 2025, growing at an annual rate of 22.5%. This rapid expansion is fuelled by innovation in hospitals, pharmaceuticals, diagnostics, and medical devices, along with rising healthcare spending by both government and private players.
Post-pandemic investments signal a strong commitment to improving healthcare infrastructure and accessibility. Additionally, increasing health awareness among consumers is driving demand for quality healthcare services. Two companies aggressively expanding in this landscape are Dr Agarwal’s Healthcare and Krishna Institute of Medical Sciences (KIMS).
Both have a dominant presence in southern India and are now setting their sights on broader national growth. A closer look at their financials, profitability, and growth strategy reveals which one is better positioned for long-term success. Dr Agarwal’s Healthcare, incorporated in 2010, is India’s largest eye care service provider, commanding a 25% market share.
It offers a comprehensive range of eye care services, including optical retail, contact lenses, accessories, and eye care pharmaceuticals. The company follows a three-tier business model, where primary centers handle basic eye care and teleconsultations, secondary centers perform cataract surgeries, and tertiary centers focus on complex procedures. This model helps optimize resources and reduce costs.
Read more on livemint.com
